性激素,抗癌免疫反应,以及治疗机会
Fabio Conforti1, Laura Pala2, Diletta Di Mitri3
1Division of Medical Oncology, Humanitas Gavazzeni, Bergamo, Italy; Humanitas University, Milan, Italy.
Cancer cell
|March 11, 2025
概括
性激素显著影响癌症免疫力和免疫治疗反应. 了解这些基于性别的差异可以导致个性化癌症治疗和新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
背景情况:
- 在癌症发病率,预后和对免疫检查点抑制剂 (ICI) 的反应方面存在基于性别的差异.
- 这些差异部分是由于抗癌免疫反应的性激素介导的变化.
- 瘤免疫微环境 (TME) 是由性激素形成的,影响免疫疗法的有效性.
研究的目的:
- 提供性激素如何调节先天性和适应性免疫的全面概述.
- 阐明性激素在塑造TME和抗癌免疫反应中的作用.
- 讨论将性激素操纵与免疫治疗相结合的潜力.
主要方法:
- 文献综述和综合有关性激素,免疫力和癌症的现有研究.
- 分析性激素对免疫细胞和TME的影响的分子机制.
- 关于癌症治疗中性激素调节的临床前和临床数据的讨论.
主要成果:
- 性激素对免疫细胞的功能,细胞因子的产生和免疫细胞透到TME有不同的影响.
- 这些荷尔蒙影响导致瘤发育和进展的性别差异.
- 有证据表明,操纵性激素可以改变对瘤和免疫治疗的免疫反应.
结论:
- 基于性别的观点对于推进瘤学的精准医学至关重要.
- 针对性激素为新型抗癌免疫治疗策略提供了一个有希望的途径.
- 需要进一步的研究来克服挑战,并优化涉及性激素操纵和免疫治疗的组合疗法.
更多相关视频
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.5K
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
14.6K
相关概念视频
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Target Cell Response to Hormones
2.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
2.8K
Cancer Vaccines
321
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
321
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
